Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma

[1]  J. Ward,et al.  Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines , 2021, Clinical liver disease.

[2]  Gaurav,et al.  Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research , 2021, Frontiers in Pharmacology.

[3]  Pengfei Gao,et al.  The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study , 2021, Frontiers in Microbiology.

[4]  T. Farkhondeh,et al.  The role of curcumin in aging and senescence: Molecular mechanisms. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  J. Schwartz,et al.  Hepatocellular Carcinoma: Epidemiology, Screening, and Assessment of Hepatic Reserve. , 2020, Current oncology.

[6]  Elise Adrian Ostrander,et al.  Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications , 2020, Frontiers in Pharmacology.

[7]  D. R. Lewis,et al.  Re: Annual Report to the Nation on the Status of Cancer, Part I: National Cancer Statistics. , 2020, The Journal of urology.

[8]  J. Pawlotsky,et al.  EASL recommendations on treatment of hepatitis C - Final update of the series. , 2020, Journal of hepatology.

[9]  J. Ferlay,et al.  International trends in hepatocellular carcinoma incidence, 1978–2012 , 2020, International journal of cancer.

[10]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[11]  D. Schuppan,et al.  Mitochondrial oxidative injury: A key player in nonalcoholic fatty liver disease. , 2020, American journal of physiology. Gastrointestinal and liver physiology.

[12]  L. Martin,et al.  Carcinoma hepatocelular , 2020, Medicine - Programa de Formación Médica Continuada Acreditado.

[13]  M. Giordano,et al.  Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics , 2020, Cancers.

[14]  Edward L. Giovannucci,et al.  Global Burden of 5 Major Types Of Gastrointestinal Cancer. , 2020, Gastroenterology.

[15]  T. Nguyen,et al.  Potential Antimicrobial and Anticancer Activities of an Ethanol Extract from Bouea macrophylla , 2020, Molecules.

[16]  V. Vo,et al.  Atypical Lindenane-Type Sesquiterpenes from Lindera myrrha , 2020, Molecules.

[17]  A. Di Leo,et al.  Curcumin and Colorectal Cancer: From Basic to Clinical Evidences , 2020, International journal of molecular sciences.

[18]  S. Ikramuddin,et al.  Nonalcoholic Steatohepatitis: A Review. , 2020, JAMA.

[19]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[20]  A. Kinghorn,et al.  Current status and contemporary approaches to the discovery of antitumor agents from higher plants. , 2020, Biotechnology advances.

[21]  S. Alavian,et al.  The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017 , 2019, Clinical liver disease.

[22]  M. Mohan.  Indian medicinal plants used as immunomodulatory agents: A review , 2019 .

[23]  Zhenqiang Zhang,et al.  Protective effects of curcumin against chronic alcohol-induced liver injury in mice through modulating mitochondrial dysfunction and inhibiting endoplasmic reticulum stress , 2019, Food & nutrition research.

[24]  Gregory J. Gores,et al.  A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.

[25]  M. Al-Thani,et al.  An overview of the Hepatitis C control plan in Qatar. , 2019, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[26]  L. Jeng,et al.  Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model , 2019, Scientific Reports.

[27]  E. Kobetz,et al.  Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity , 2019, JHEP reports.

[28]  R. Rahbarghazi,et al.  Curcumin inhibits angiogenesis in endothelial cells using downregulation of the PI3K/Akt signaling pathway , 2019, Food Bioscience.

[29]  Shujiro Okuda,et al.  Autophagy regulates lipid metabolism through selective turnover of NCoR1 , 2019, Nature Communications.

[30]  Wei Zhang,et al.  Curcumin inhibits liver metastasis of gastric cancer through reducing circulating tumor cells , 2019, Aging.

[31]  R. Peeling,et al.  Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. , 2019, The lancet. Gastroenterology & hepatology.

[32]  P. Nahon,et al.  Hepatocellular carcinoma in the setting of alcohol-related liver disease. , 2019, Journal of hepatology.

[33]  Muhammad Maqsood Alam,et al.  Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  M. Alboraie,et al.  Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations , 2018, World journal of gastroenterology.

[35]  Ahmedin Jemal,et al.  Cancer Statistics for Hispanics/Latinos, 2018 , 2018, CA: a cancer journal for clinicians.

[36]  Hua-Bin Li,et al.  Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives , 2018, Nutrients.

[37]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[38]  Li Li,et al.  Janus nanocarriers for magnetically targeted and hyperthermia-enhanced curcumin therapy of liver cancer , 2018, RSC advances.

[39]  B. Armstrong.  Cancer Epidemiology and Prevention , 2018, International Journal of Epidemiology.

[40]  P. Poczai,et al.  A revision of the Old World Black Nightshades (Morelloid clade of Solanum L., Solanaceae) , 2018, PhytoKeys.

[41]  F. Boscoe,et al.  Cancer Site–Specific Disparities in New York, Including the 1945–1965 Birth Cohort's Impact on Liver Cancer Patterns , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[42]  A. Jemal,et al.  Annual report to the nation on the status of cancer, part I: National cancer statistics , 2018, Cancer.

[43]  M. Farzaei,et al.  Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective , 2018, Nutrients.

[44]  L. Poretsky,et al.  Phyto-polyphenols as potential inhibitors of breast cancer metastasis , 2018, Molecular Medicine.

[45]  J. Iqbal,et al.  Potential phytocompounds for developing breast cancer therapeutics: Nature’s healing touch , 2018, European journal of pharmacology.

[46]  C. la Vecchia,et al.  Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors , 2018, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[47]  Ji Wang,et al.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway. , 2018, Experimental and therapeutic medicine.

[48]  I. S. Ismail,et al.  Metabolite characterization of different palm date varieties and the correlation with their NO inhibitory activity, texture and sweetness , 2018, Journal of Food Science and Technology.

[49]  Zhengjie Huang,et al.  Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression , 2018, Oncology letters.

[50]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[51]  Yoshiyuki Suzuki,et al.  Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus , 2017, Journal of medical virology.

[52]  A. I. Joseph,et al.  The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites , 2017, The Journal of Biological Chemistry.

[53]  A. Shehzad,et al.  Multifunctional Curcumin Mediate Multitherapeutic Effects. , 2017, Journal of food science.

[54]  Sumio Watanabe,et al.  Pathophysiology of Nonalcoholic Steatohepatitis , 2017 .

[55]  A. Galli,et al.  Chemotherapy for hepatocellular carcinoma: The present and the future , 2017, World journal of hepatology.

[56]  Liying Li,et al.  Kaempferol induces hepatocellular carcinoma cell death via endoplasmic reticulum stress-CHOP-autophagy signaling pathway , 2017, Oncotarget.

[57]  M. Russo,et al.  Viral hepatitis and hepatocellular carcinoma: etiology and management. , 2017, Journal of gastrointestinal oncology.

[58]  Zhimou Yang,et al.  A Glycyrrhetinic Acid-Modified Curcumin Supramolecular Hydrogel for liver tumor targeting therapy , 2017, Scientific Reports.

[59]  Xiaoping Zhou,et al.  Investigation of the anti-cancer effect of quercetin on HepG2 cells in vivo , 2017, PloS one.

[60]  D. Lucero,et al.  New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans , 2017, PloS one.

[61]  Gamal Esmat,et al.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.

[62]  R. Siegel,et al.  Cancer Mortality in Hispanic Ethnic Groups , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[63]  Uchenna Okonkwo,et al.  Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. , 2017, The lancet. Gastroenterology & hepatology.

[64]  P. Rijo,et al.  Phytosomes as Biocompatible Carriers of Natural Drugs. , 2017, Current medicinal chemistry.

[65]  F. Bray,et al.  Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12 , 2017, International journal of cancer.

[66]  S. Maddocks,et al.  Chemical characterisation and the anti-inflammatory, anti-angiogenic and antibacterial properties of date fruit (Phoenix dactylifera L.). , 2016, Journal of ethnopharmacology.

[67]  R. Ahmad,et al.  Effect of ethyl acetate aroma on viability of human breast cancer and normal kidney epithelial cells in vitro , 2016, Integrative medicine research.

[68]  H. Eguchi,et al.  Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice , 2016, Hepatology.

[69]  D. S̆timac,et al.  Nonalcoholic fatty liver disease - A multisystem disease? , 2016, World journal of gastroenterology.

[70]  G. Fimia,et al.  Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[71]  P. Easterbrook,et al.  Hepatitis C: global epidemiology and strategies for control. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[72]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.

[73]  H. Kwon,et al.  Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation , 2016, BMC Complementary and Alternative Medicine.

[74]  C. Liu,et al.  Association of different types of liver disease with demographic and clinical factors , 2016, BioMedicine.

[75]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[76]  A. Cianciulli,et al.  PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia. , 2016, International immunopharmacology.

[77]  Vikram Patel,et al.  Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet.

[78]  H. Salehiniya,et al.  The Incidence and Mortality of Liver Cancer and its Relationship with Development in Asia , 2016 .

[79]  D. Ghosh,et al.  Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride–mediated oxidative hepatocellular damage in rat model , 2016, International journal of nanomedicine.

[80]  Jun Li,et al.  Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients. , 2016, Cancer cell.

[81]  Ahmedin Jemal,et al.  Annual Report to the Nation on the Status of Cancer, 1975‐2012, featuring the increasing incidence of liver cancer , 2016, Cancer.

[82]  Yeu-Ching Shi,et al.  Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells , 2016, Molecules.

[83]  M. Hasan,et al.  In Vivo Evaluation of Anti Diabetic, Hypolipidemic, Antioxidative Activities of Saudi Date Seed Extract on Streptozotocin Induced Diabetic Rats. , 2016, Journal of clinical and diagnostic research : JCDR.

[84]  M. Ramirez-Tortosa,et al.  Curcumin and Health , 2016, Molecules.

[85]  Š. Kubínová,et al.  The Anti-Inflammatory Compound Curcumin Enhances Locomotor and Sensory Recovery after Spinal Cord Injury in Rats by Immunomodulation , 2015, International journal of molecular sciences.

[86]  Jason A. Dominitz,et al.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. , 2015, Gastroenterology.

[87]  K. Huse,et al.  A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis , 2015, Nature Genetics.

[88]  Y. Chawla,et al.  Immunology of hepatocellular carcinoma. , 2015, World journal of hepatology.

[89]  Eunjung Kim,et al.  Curcumin ameliorates the tumor-enhancing effects of a high-protein diet in an azoxymethane-induced mouse model of colon carcinogenesis. , 2015, Nutrition research.

[90]  A. Elmarakby,et al.  Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats , 2015, PloS one.

[91]  C. Tai,et al.  Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells , 2015, Evidence-based complementary and alternative medicine : eCAM.

[92]  C. Tai,et al.  Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells , 2015, Integrative cancer therapies.

[93]  G. Peters,et al.  Drug transport and metabolism of novel anticancer drugs , 2015, Expert opinion on drug metabolism & toxicology.

[94]  Xi Zheng,et al.  Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? , 2015, Molecules.

[95]  Henry E. Wang,et al.  Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department , 2015, Hepatology.

[96]  L. Kulik,et al.  Evaluation and management of hepatocellular carcinoma. , 2015, Clinics in liver disease.

[97]  M. Kanter,et al.  Antioxidative, antiapoptotic, and proliferative effect of curcumin on liver regeneration after partial hepatectomy in rats , 2015, Toxicology and industrial health.

[98]  Y. Panahi,et al.  Adjuvant Therapy with Bioavailability‐Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double‐Blind Placebo‐Controlled Trial , 2014, Phytotherapy research : PTR.

[99]  B. Vimala,et al.  Essential oil composition of eight starchy Curcuma species , 2014 .

[100]  S. Acharya.  Epidemiology of hepatocellular carcinoma in India. , 2014, Journal of clinical and experimental hepatology.

[101]  H. El‐Serag,et al.  HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV , 2014, Hepatology.

[102]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.

[103]  Q. Zia,et al.  Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals , 2014, International journal of nanomedicine.

[104]  Omar Hamed,et al.  Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. , 2014, European journal of pharmacology.

[105]  Massimo Mirabito,et al.  Data Harmonization Process for Creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas , 2014, Public health reports.

[106]  T. Guo,et al.  Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway. , 2013, International journal of oncology.

[107]  G. Abou-Alfa,et al.  Status of hepatocellular carcinoma in Gulf region. , 2013, Chinese clinical oncology.

[108]  D. Jagatheeswari.  Black Night Shade Solanum nigrum L An Updated Overview , 2013 .

[109]  M. Kew.  Aflatoxins as a cause of hepatocellular carcinoma. , 2013, Journal of gastrointestinal and liver diseases : JGLD.

[110]  N. Yang,et al.  Therapeutic Applications of Herbal Medicines for Cancer Patients , 2013, Evidence-based complementary and alternative medicine : eCAM.

[111]  A. Elshater,et al.  The hepato-ameliorating effect of Solanum nigrum against CCl4 induced liver toxicity in Albino rats , 2013 .

[112]  Guang-wen Wu,et al.  Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis. , 2013, International journal of oncology.

[113]  A. Ragab,et al.  Antioxidant and tissue-protective studies on Ajwa extract: dates from Al Madinah Al-Monwarah, Saudia Arabia , 2012 .

[114]  C. Tai,et al.  Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells , 2012, Evidence-based complementary and alternative medicine : eCAM.

[115]  Ying-jian Liang,et al.  In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog , 2012, PloS one.

[116]  R. Santella,et al.  The Role of Aflatoxins in Hepatocellular Carcinoma , 2012, Hepatitis monthly.

[117]  Rebecca L Morgan,et al.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[118]  F. Bray,et al.  Cancer mortality in India: a nationally representative survey , 2012, The Lancet.

[119]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[120]  J. Essigmann,et al.  Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[121]  Angelique Zeringue,et al.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.

[122]  Chia-min Lin,et al.  Determination of bactericidal efficacy of essential oil extracted from orange peel on the food contact surfaces , 2010 .

[123]  H. El‐Serag,et al.  Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[124]  Yun-Ching Chang,et al.  Solanum nigrum Linn. water extract inhibits metastasis in mouse melanoma cells in vitro and in vivo. , 2010, Journal of agricultural and food chemistry.

[125]  E. Chang,et al.  Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[126]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[127]  Jen-kun Lin,et al.  Chemical composition of Solanum nigrum linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells. , 2010, Journal of agricultural and food chemistry.

[128]  S. D. L. Monte,et al.  Oxidative Medicine and Cellular Longevity , 2019 .

[129]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[130]  K. Gauthaman,et al.  Phytochemical and pharmacological evaluation of Solanum nigrum Linn. , 2009 .

[131]  S. Park,et al.  Perilla leaf, Perilla frutescens, induces apoptosis and G1 phase arrest in human leukemia HL-60 cells through the combinations of death receptor-mediated, mitochondrial, and endoplasmic reticulum stress-induced pathways. , 2009, Journal of medicinal food.

[132]  Julie S. Jurenka.  Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.

[133]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[134]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[135]  K. Suresh,et al.  Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: implications for immunoadjuvant potential. , 2009, Journal of ethnopharmacology.

[136]  A. Shirwaikar,et al.  Curcuma zedoaria Rosc. (white turmeric): a review of its chemical, pharmacological and ethnomedicinal properties , 2009 .

[137]  M. Lemoine,et al.  Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. , 2008, Diabetes & metabolism.

[138]  Kun Li,et al.  Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells. , 2008, Fitoterapia.

[139]  K. Lee,et al.  Recent advances in the investigation of curcuminoids , 2008, Chinese medicine.

[140]  S. Rai,et al.  The effect of the aqueous extract of the roots of Asparagus racemosus on hepatocarcinogenesis initiated by diethylnitrosamine , 2008, Phytotherapy research : PTR.

[141]  I. Gülçin,et al.  Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.

[142]  L. Koniaris,et al.  Interleukin-6 mediates G(0)/G(1) growth arrest in hepatocellular carcinoma through a STAT 3-dependent pathway. , 2008, The Journal of surgical research.

[143]  F. Chou,et al.  Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats. , 2008, Chemico-biological interactions.

[144]  B. Aggarwal,et al.  Curcumin as "Curecumin": from kitchen to clinic. , 2008, Biochemical pharmacology.

[145]  David S Ziegler,et al.  Therapeutic targeting of apoptosis pathways in cancer , 2008, Current opinion in oncology.

[146]  Peter Libby,et al.  Inflammatory mechanisms: the molecular basis of inflammation and disease. , 2007, Nutrition reviews.

[147]  K. Madan,et al.  Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India. , 2007, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[148]  J. Goodwin,et al.  Epidemiology of hepatocellular carcinoma in Hispanics in the United States. , 2007, Archives of internal medicine.

[149]  P. Hewson,et al.  Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. , 2007, Health technology assessment.

[150]  Chao‐Lin Kuo,et al.  Growth inhibitory and apoptosis inducing effect of Perilla frutescens extract on human hepatoma HepG2 cells. , 2007, Journal of ethnopharmacology.

[151]  C. Chyau,et al.  Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. , 2007, Journal of agricultural and food chemistry.

[152]  S. Saxena,et al.  Asparagus racemosus--ethnopharmacological evaluation and conservation needs. , 2007, Journal of ethnopharmacology.

[153]  S. Sagar,et al.  Targeting Angiogenesis With Integrative Cancer Therapies , 2006, Integrative cancer therapies.

[154]  A. McCullough.  Pathophysiology of nonalcoholic steatohepatitis. , 2006, Journal of clinical gastroenterology.

[155]  B. Vimala,et al.  Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. , 2005, Journal of ethnopharmacology.

[156]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[157]  A. Panahloo,et al.  The advantages and disadvantages of a ‘herbal’ medicine in a patient with diabetes mellitus: a case report , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[158]  T. Yoshikawa,et al.  Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. , 2003, Carcinogenesis.

[159]  G. Jacquemin.  [Nonalcoholic steatohepatitis: a review]. , 2003, Revue medicale de Liege.

[160]  H. Chiou,et al.  Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B , 2002, Hepatology.

[161]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[162]  J. P. Kamat,et al.  Antioxidant properties of Asparagus racemosus against damage induced by gamma-radiation in rat liver mitochondria. , 2000, Journal of ethnopharmacology.

[163]  C. Chu.  Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma , 2000, Journal of gastroenterology and hepatology.

[164]  M. Hashizume,et al.  A Long‐term Follow‐up Study on Risk Factors for Hepatocellular Carcinoma among Japanese Patients with Liver Cirrhosis , 1998, Japanese journal of cancer research : Gann.

[165]  M. Ali.  Rasayana therapy in classical literature of Ayurveda: a review. , 1998, Bulletin of the Indian Institute of History of Medicine.

[166]  C. J. Chen,et al.  Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. , 1997, Journal of hepatology.

[167]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[168]  Y. Chawla,et al.  Immunology of hepatocellular carcinoma. , 1991, The Italian journal of gastroenterology.

[169]  G. Práctica,et al.  European Association for the Study of the Liver , 1971 .

[170]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[171]  G. Marchesini,et al.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. , 2019, Transplantation.

[172]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[173]  Amin Jalili,et al.  Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[174]  A. El-Karef,et al.  Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways. , 2017, Annals of hepatology.

[175]  Hui Zhang,et al.  Effects of Alcohol on Tumor Growth, Metastasis, Immune Response, and Host Survival , 2015, Alcohol research : current reviews.

[176]  Luís Alexandre Pedro de Freitas,et al.  Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells. , 2013, Neurotoxicology.

[177]  P. Goswami,et al.  A review through Charaka Uttara-Tantra , 2013, Ayu.

[178]  T. Wiedmann.  DEPARTMENT OF PHARMACEUTICS, I , 2013 .

[179]  S. Bhattacharyya,et al.  Curcumin: the multi-targeted therapy for cancer regression. , 2012, Frontiers in bioscience.

[180]  L. Serino,et al.  Hepatitis B: Epidemiology and prevention in developing countries. , 2012, World journal of hepatology.

[181]  J. Essigmann,et al.  Aflatoxin B 1-DNA Adduct Formation and Mutagenicity in Livers of Neonatal Male and Female B 6 C 3 F 1 Mice , 2011 .

[182]  Jun-jie Yu,et al.  Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[183]  Z. Zhi-yong.  Advances in studies on saponins in plants of Paris L.and their biosynthetic approach , 2009 .

[184]  Chang Yong Lee,et al.  Nutritional and Functional Properties of Dates: A Review , 2008, Critical reviews in food science and nutrition.

[185]  N. Khaisombat,et al.  Investigation the antinociceptive, antipyretic and anti- inflammatory activities of Curcuma aeruginosa Roxb. extracts in experimental animals , 2006 .

[186]  W. Xiao.  The mitochondrial pathways of apoptosis , 2002 .

[187]  R. Gaur,et al.  Flora of the District Garhwal North West Himalaya (With Ethnobotanical Notes) , 2001 .

[188]  V. Kumar,et al.  Chemistry of Ayurvedic Crude Drugs — VII11Part VI, Indian J. Chem., in press. guggulu (Resin From Commiphora Mukul) —6 , 1987 .

[189]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[190]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.

[191]  Erratum: Global Cancer Statistics , 2022 .